Vaccines Market Insights: Size, Business Dynamics, Industry Expansion, and Future Forecasts Up to 2028
In August 2022, GSK (UK) acquired Affinivax, Inc. (US) to have access to next-generation 24-valent pneumococcal vaccine candidate.
View full press release